2010
Tumor-associated macrophages predict long-term survival in classical Hodgkin Lymphoma [PMC2897174; PMID20220182]
C Steidl;T Lee;SP Shah;P Farinha;G Han;T Naya;A Dalaney;SJ Jones;M Bast;J Iqbal;A Rosenwald;L Rimsza;E Campo;ES Jaffe;G Lenz;JM Connors;LM Staudt;WC Chan;RD Gascoyne New England Journal of Medicine, 3621(10):875-885
Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma [PMC2845535; PMID20054396]
RE Davis;G Lenz;P Tolar;RM Young;PB Romesser;H Kohlhammer;L Lamy;H Zhao;Y Yang;W Xu;A Shaffer;G Wright;W Xiao;J Powell;JK Jiang;CJ Thomas;A Rosenwald;G Ott;HK Muller-Hermelink;RD Gascoyne;JM Connors;NA Johnson;L Rimsza;E Campo;E Jaffe;WH Wilson;J Delabie;EB Smeland;RI Fisher;R Braziel;R Tubbs;JR Cook;DD Weisenburger;WC Chan;SK Pierce;LM Staudt Nature 463(7277):88-92
Effect of complete remission and responses less than complete remission on survival in acute myeloid leukemia: a combined Eastern Cooperative Oncology Group, Southwest Oncology Group, and M.D. Anderson Cancer Center study [PMC2849766; PMID20159819]
RB Walter;HM Kantarjian;X Huang;SA Pierce;Z Sun;H Gundacker;F Ravandi;S Faderl;M Tallman;F Appelbaum Journal of Clinical Oncology 28(10):1766-1771
Pathway discovery in mantle cell lymphoma by integrated analysis of high-resolution gene expression and copy number profiling[PMC2924229; PMID20421449]
E Hartmann;E Campo;G Wright;G Lenz;I Salaverria;P Jares;W Xiao;R Braziel;L Rimsza;W-C Chan;T Weisenburger;J Delabie;E Jaffe;R Gascoyne;S Dave;H-K Mueller-Hermelink;LM Staudt;G Ott;S Bea;A Rosenwald Blood 116(6):953-961
Genetic polymorphisms in oxidative stress-related genes correlated with outcome following anthracycline-based therapy for aggressive B-cell non-hodgkins lymphomas
H Tardif;S Yao;B Goldman;C Spier;M LeBlanc;L Rimsza;D Persky;T Miller;RI Fisher;C Ambrosone;M Briehl Blood 116:abst.#321; American Society of Hematology 2010 Annual Meeting; oral
2009
Accurate classification of diffuse large cell lymphoma into germinal center and activated B cell subtypes using a nuclease protection assay on formalin fixed paraffin embedded: a study from the Lymphoma and Leukemia Molecular Profiling Project
LM Rimsza;GL Wright;M Schwartz;J Chan;E Jaffe;R Gascoyne;E Campo;A Rosenwald;G Ott;J Cook;RR Tubbs;R Braziel;J Delabie;T Miller;RI Fisher;L Staudt Blood 114:abst. #620, 2009 (ASH Annual Meeting, oral presentation)
High microvascular density correlates independently with poor outcome in patients with diffuse large B-cell lymphoma (DLBCL) treated with rituximab plus chemotherapy (R-CT)
T Cardesa;L Colomo;F Climent;E Gonzalez-Barca;G Gutierrez;M Mercadal;R Gascoyne;JM Connors;LM Rimsza;RM Braziel;J Cook;R Tubbs;A Rosenwald;G Ott;J Mate;J Ribera;L Arenillas;S Serrano;N Combalia;J Delabie;G Lenz;G Wright;E Jaffe;L Staudt;W Chan;D Weissenburger;A Lopez-Guillermo;E Campo Blood 114:abst. #1948 (ASH Annual Meeting, poster presentation)
Chromosomal alterations in gene expression-defined pediatric aggressive B-cell non-hodgkin lymphomas (B-NHL)
K Deffenbacher;J Iqbal;Z Liu;S Perkins;M Lim;K Fu;J Shen;L Staudt;L Rimsza;E Jaffe;A Rosenwald;J Delabie;J Campo;R Gascoyne;D Weisenberger;T Greiner;TG Gross;W Chan Blood 114 abst. #2922 (ASH Annual Meeting, poster presentation)
MYC translocations and expression are clinically important in R-CHOP treated patients with de novo DLBCL
NA Johnson;S Ben-Neriah;KJ Savage;T Lee;DE Horsman;JM Connors;WC Chan;G Lenz;G Wright;L Rimsza;RM Braziel;J Cook;R Tubbs;D Weisenburger;E Campo;A Rosenwald;G Ott;J Delabie;E Jaffe;LM Staudt;RD Gascoyne Blood 114:abst. 1100 (ASH Annual Meeting, poster presentation)
Follicular lymphomas with and without translocation t(14:18) differ in gene expression profiles and genetic alterations [PMID19471018; PMC2716022]
E Leich;I Salaverria;S Bea;A Zettl;G Wright;V Moreno;RD Gascoyne;RM Braziel;L Rimsza;DD Weisenburger;J Delabie;ES Jaffe;A Lister;J Fitzgibbon;LM Staudt;EM Hartmann;HK Mueller-Hermelink;E Campo;G Ott;A Rosenwald Blood 114:826-834
Array-based DNA methylation profiling in follicular lymphoma
C O'Riain;DM O'Shea;Y Yang;R LeDieu;JF Gribben;K Summers;J Yeboah-Afari;L Bhaw-Rosun;C Fleischmann;CA Mein;T Crook;P Smith;G Kelly;A Rosenwald;G Ott;E Campo;L Rimsza;EB Smeland;WC Chan;N Johnson;RD Gascoyne;S Reimer;R Braziel;WG Wright;LM Staudt;TA Lister;J Fitzgibbon Leukemia 23(10):1858-1866
SOX11 expression is highly specific for mantle cell lymphoma and identifies the cyclin D1 negative subtype [PMID19880778; PMC2770966]
A Mozos;C Royo;E Hartmann;D DeJong;C Baro;A Valera;K Fu;DD Weisenburger;J Delabie;SS Chuang;ES Jaffe;S Dave;L Rimsza;R Braziel;RD Gascoyne;F Sole;A Lopez-Guillermo;D Colomer;LM Staudt;A Rosenwald;G Ott;P Jares;E Campo Haematologica 94(11):1555-1562
2008
Molecular subtypes of diffuse large b cell lymphoma arise by distinct genetic pathways [PMC2533222; PMID18765795]
G Lenz;GW Wright;T Emre;H Kohlhammer;S Dave;RE Davis;S Carty;LT Lam;AL Shaffer;W Xiao;J Powell;A Rosenwald;G Ott;HK Muller-Hermelink;R Gascoyne;JM Connors;E Campo;E Jaffe;EB Delabie;EB Smeland;LM Rimsza;RJ Fisher;DD Weisenburger;W Chan;LM Staudt Proceedings of the National Academy of Sciences 105(36):13520-13525
Stromal gene signatures in large-B-cell lymphomas [PMID19038878]
G Lenz;G Wright;S Dave;W Xiao;J Powell;H Zhao;W Xu;B Tan;N Goldschmidt;J Iqbal;J Vose;M Bast;K Fu;D Weisenburger;T Greiner;JO Armitage;A Kyle;L May;R Gascoyne;JM Connors;G Troen;H Holte;S Kvaloy;D Kierickx;G Verhoef;J Delabie;E Smeland;P Jares;A Martinez;A Lopez-Guillermo;E Montsarrat;E Campo;R Braziel;TP Miller;LM Rimsza;JR Cook;B Pohlman;JW Sweetenham;RR Tubbs;RI Fisher;E Hartmann;A Rosenwald;G. Ott;HK Muller-Hermelink;D Wrench;T Lister;E Jaffe;W Wilson;W Chan;L Staudt New England Journal of Medicine 359(22)2313-2323
Non-hodgkins lymphoma
R Fisher;P Mauch;J Friedberg;L Rimsza In Cancer: Principles and Practice of Oncology, 8th edition, Lippincott, Williams & Wilkins, Baltimore, MD, pp 2098-2158, 2008
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma [PMID: 183233416]
G Lenz;RE Davis;VN Ngo;L Lamb;TC George;GW Wright;SS Dave;H Zhao;W Xu;A Rosenwald;G Ott;HK Muller-Hermelink;R Gascoyne;JM Connors;LM Rimsza;E Campo;E Jaffe;J Delabie;EB Smeland;RI Fisher;WC Chan;LM Staudt Science 319:1676-1679
Molecular signatures implicate innate immune cells, fibrosis, and angiogenesis in survival following R-CHOP treatment of diffuse large B cell lymphoma
G Lenz;G Wright;SS Dave;W Xiao;H Zhao;W Xu;B Tan;N Goldschmidt;J Iqbal;J Vose;M Bast;K Fu;DD Weisenburger;TC Greiner;JO Armitage;A Kyle;L May;RD Gascoyne;JM Connors;G Troen;H Holte;H Holte;S Kvaloy;D Dierickx;G Verhoef;J Delabie;EB Smeland;P Jares;A Martinez;A Lopez-Guillermo;E Montserrat;E Campo;RM Braziel;TP Miller;LM Rimsza;JR Cook;B Pohlman;JW Sweetenham;RR Tubbs;RI Fisher;E Hartmann;A Rosenwald;G Ott;HK Muller-Hermelink;D Wrench;TA Lister;ES Jaffe;WH Wilson;LM Staudt Blood 112(11)181 abst. 475
Genome-wide expression profiling predicts treatment outcome in classical hodgkin lymphoma
C Steidl;T Lee;SP Shah;G Han;T Nayar;A Delaney;WC Chan;A Rosenwald;LM Rimsza;E Campo;ES Jaffe;LM Staudt;G Lenz;JM Connors;RD Gascoyne Blood 112(11):196 Abst. 520
Genetic abnormalities involved in the development and progression of follicular lymphoma
KE Deffenbacher;GL Wright;J Iqbal;H Geng;D O'Shea;TA Lister;JF Fitzgibbon;K Fu;A Liu;D Weisenburger;TC Greiner;RD Gascoyne;A Rosenwald;E Campo;LM Rimsza;J Delabie;ES Jaffe;LM Staudt;WC Chan Blood 112(11):714, Abst. 2049
2007
Aberrant immunoglobulin class switch recombination and switch translocations in activated B cell-like diffuse large B cell lymphoma [PMID17353367; PMC2137913]
G Lenz;I Nagel;R Siebert;AV Roschke;W Sanger;GW Wright;SS Dave;B Tan;H Zhao;A Rosenwald;HK Muller-Hermelink;RD Gascoyne;E Campo;ES Jaffe;EB Smeland;RI Fisher;WM Kuehl;WC Chan;LM Staudt Journal of Experimental Medicine 204:633-643
Point mutations and genomic deletions in CCND1 create stable truncated cyclin D1 mRNAs that are associated with increased proliferation rate and shorter survival [PMID17299095; PMC1885523]
A Wiestner;M Tehrani;M Chiorazzi;G Wright;F Gibellini;K Nakayama;H Liu;A Rosenwald;HK Muller-Hermelink;G Ott;WC Chan;TC Greiner;DD Weisenburger;J Vose;JO Armitage;RD Gascoyne;JM Connors;E Campo;E Montserrat;F Bosch;EB Smeland;S Kvaloy;H Holte;J Delabie;RI Fisher;TM Grogan;TP Miller;WH Wilson;EJ Jaffe;LM Staudt Blood 109(11):4599-4606
Frequent occurrence of deletions in primary mediastinal B-cell lymphoma [PMID17823928]
LR Kimm;RJ deLeeuw;KJ Savage;A Rosenwald;E Campo;J Delabie;G Ott;HK Muller-Hermelink;ES Jaffe;LM Rimsza;DD Weisenburger;WC Chan;LM Staudt;JM Connors;RD Gascoyne;WL Lam Genes, Chromosomes & Cancer 46:1090-1097
Distinct genetic aberrations in molecular sybtypes of diffuse large B cell lymphoma detected by array CGH
G Lenz;GW Wright;S Dave;W Xiao;J Powell;A Rosenwald;HK Muller-Hermelink;RD Gascoyne;JM Connors;E Campo;ES Jaffe;J Delabie;EB Smeland;LM Rimsza;RI Fisher;WC Chan;LM Staudt Blood 2110(11):#2631
Gene expression model of survival and transformation in follicular lymphoma (FL): a study by the LLMPP
NA Johnson;T Nayar;SS Dave;G Wright;A Rosenwald;WC Chan;M Bast;LM Rimsza;H Holte;J Delabie;JM Connors;A Al-Tourah;L Colomo;E Campo;T Lister;D O'Shea;LM Staudt;RD Gascoyne Blood 110(11):#2606
Follicular lymphomas with and without translocation t(14;18) differ in gene expression profiles and genetic alterations
E. Leich;I Salaverria;S Bea;A Zettl;RD Gascoyne;WC Chan;RM Braziel;LM Rimsza;DD Weisenburger;J Delabie;ES Jaffe;TA Lister;AJ Norton;LM Staudt;EM Hartmann;HK Mueller-Hermelink;E Campo;G Ott;A Rosenwald Blood 110(11)#360
Distinctive patters of BCL6 molecular alterations and their functional consequences in different subgroups of diffuse large B-cell lymphoma [PMID17625604;PMC2366166]
J Iqbal;T Greiner;K Patel;BJ Dave;L Smith;J Ji;G Wright;WG Sanger;DL Pickering;S Jain;DE Horsman;Y Shen;K Fu;DD Weisenburger;CP Hans;E Campo;RD Gascoyne;A Rosenwald;ES Jaffe;J Delabie;L Rimsza;G Ott;HK Muller-Hermelink;JM Connors;JM Vose;T McKeithan;LM Staudt;WC Chan Leukemia 21(11)2332-2343
Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma [PMID17881637; PMC2234786]
KH Young;DD Weisenberger;B Dave;L Smith;W Sanger;E Campo;J Delabie;RD Gascoyne;LM Rimsza;HK Muller-Hermelink;ES Jaffe;A Rosenwald;LM Staudt;WC Chan;TC Greiner Blood 110(13):4396-4405
CARD11 as an oncogene in diffuse large B cell lymphoma
G Lenz;RE Davis;VN Ngo;LT Lam;T George;GW Wrights;SS Dave;H Zhao;W Xu;A Rosenwald;H Muller-Hermelink;RD Gascoyne;JM Connors;E Campo;E Jaffe;J Delabie;EB Smeland;LM Rimsza;RI Fisher;WC Chan;LM Staudt Blood 110(11):#692
Major histocompatibility class II (MHCII) and germinal center associated gene expression correlate with overall survival in ritiximab and CHOP-like treated diffuse large B cell lymphoma (DLBCL) patients using formalin fixed paraffin embedded (FFPE) tissues
LM Rimsza;M Leblanc;RA Roberts;JM Unger;TP Miller;CM Sabalos;RR Martel;E Campo;A Rosenwald;JM Connors;LH Sehn;N Johnson;RD Gascoyne Blood 110(11):#50
2004
Loss of MHC class II gene and protein expression in diffuse large B cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival regardless of other prognostic factors: a follow-up study from the leukemia and lymphoma molecular profiling project
L Rimsza;RA Roberts;TP MIller;JM Unger;M LeBlanc;R Braziel;DD Weisenburger;WC Chan;K Muller-Hermelink;ES Jaffe;RD Gascoyne;E Campo;D Fuchs;CM Spier;RI FIsher;J Delabie;A Rosenwald;LM Staudt;T Grogan Blood 103(11):4251-4258
Downregulated antioxidant defense enzyme expression is correlated with poor survival in DLBCL
DB Johnson;ME Tome;LM Rimsza;RA Roberts;LW Browne;TM Grogan;TP Miller;MM Briehl Federation of American Societies for Experimental Biology 18(5):A953 (#626.6)
Prediction of survival in follicular lymphoma based on molecular features of tumor-infiltrating immune cells
SS Dave;G Wright;B Tan;A Rosenwald;RD Gascoyne;WC Chan;RI Fisher;RM Braziel;LM Rimsza;TM Gorgan;TP Miller;M LeBlanc;TC Greiner;DD Weisenburger;JC Lynch;J Vose;JO Armitage;EB Smeland;S Kvaloy;H Holte;J Delabie;JM Connors;P Lansdorp;Q Ouyang;TA Lister;AJ Davies;AJ Norton;HK Muller-Hermelink;G Ott;E Campos;E Montserrat;WH Wilson;ES Jaffe;R Simon;L Yang;J Powell;H Zhao;N Goldschmidt;M Chiorazzi;LM Staudt New England Journal of Medicine 351(21):2159-2169
Chromosomal imbalances in germinal center B-cell like and activated B-cell like diffuse large B-cell lymphoma influence gene expression signatures and improve the gene expression-based survival prediction.
A Zettl;S Bea;G Wright;I Salaverria;P Jehn;G Ott;WC Chan;ES Jaffe;DD Weisenburger;TC Greiner;JO Armitage;RD Gascoyne;JM Connors;TM Grogan;TP Miller;RI Fisher;J Delabie;S Kvaloy;HK Mueller-Hermelink;V Moreno;E Montserrat;WH Wilson;LM Staudt;A Rosenwald;E Campo Blood 104(11): #415
Allelic loss during progression of follicular lymphoma
S Takeuchi;S de Vos;N Takeuchi;AC Fermin;TM Grogan;H Seo;JW Said;HP Koeffler Leukemia Research 28:567-569
HLA-DR protein status predicts survival in patients with diffuse large B cell lymphoma (DLBCL) treated with the MACOP-B chemotherapy regimen
LM Rimsza;P Farinha;DA Fuchs;H Masoudi;JM Connors;RD Gascoyne Blood 104(11): #3273
Gene expression profiling, frozen and paraffin section immunohistochemistry, and in situ hybridization for determination of monoclonality in diffuse large B-cell lymphoma
MW Andres;RA Roberts;DJ Mustacich;RD Gascoyne;DA Fuchs;MX Wang;RM Braziel;WC Chan;TM Grogan;LM Rimsza Blood 104(11): #4553
BCL2 translocation defines a unique tumor subset within the germinal center B-cell-llike diffuse large B-cell lymphoma
J Iqbal;WG Sanger;DE Horsman;A Rosenwald;DL Pickering;B Dave;L Xiao;K Cao;Q Zhu;S Sherman;CP Hans;CC Weisenburger;TC Greiner;RD Gascoyne;G Ott;HK Muller-Hermelink;J Delabie;RM Braziel;ES Jaffe;E Campo;JC Lynch;JC Lynch;JM Connors;JM Vose;JO Armitage;TM Grogan;LM Staudt;WC Chan American Journal of Pathology 165(1):159-166
2003
Gene expression profile of serial samples of transformed B-cell lymphomas.
S de Vos;WK Hofmann;TM Grogan;U Krug;M Schrage;TP Miller;J Braun;W Wachsman;HP Koeffler;JH Said Laboratory Investigation 83(2):271-285
Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV
S deVos;U Krug;WK Hofmann;GS Pinkus;SH Swerdlow;W Wachsman;TM Grogan;JW Said;HP Koeffler Diagnostic Molecular Pathology 12(1):35-43
Loss of MHC class II gene and protein expression in diffuse large B cell lymphoma is related to decreased tumor immunosurveillance and poor patient survival: a follow-up study to the NIH director's challenge leukemia and lymphoma molecular profiling project (LLMPP)
L Rimsza;R Roberts;T Miller;J Unger;M LeBlanc;R Braziel;D Weisenburger;WC Chan;T Greiner;K Muller-Hermelink;E Jaffe;RD Gascoyne;E Campo;D Fuchs;C Spier;R Fisher;L Staudt;T Grogan Blood 102(11):(#1417)
The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma
A Rosenwald;G Wright;A Wiestner;WC Chan;JM Connors;E Campo;RD Gascoyne;TM Grogan;HK Muller-Hermelink;EB Smeland;M Chiorazzi;JM Giltnane;EM Hurt;H Zhao;L Averett;S Henrickson;L Yang;J Powell;WH Wilson;ES Jaffe;R Simon;RD Klausner;E Montserrat;F Bosch;TC Greiner;DD Weisenburger;WG Sanger;BJ Dave;JC Lynch;J Vose;JO Armitage;RI Fisher;TP Miller;M LeBlanc;G Ott;S Kvaloy;H Holte;H Delabie;LM Staudt Cancer Cell 3:185-197
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald;G Wright;K Leroy;X Yu;P Gaulard;RD Gascoyne;WC Chan;T Zhao;C Haioun;TC Greiner;DD Weisenburger;JC Lynch;J Vose;JO Armitage;EB Smeland;S Kvaloy;H Holte;J Delabie;E Campo;E Monserrat;A Lopez-Guillermo;G Ott;HK Muller-Hermelink;JM Connors;RM Braziel;TM Grogan;RI Fisher;TP Miller;M LeBlanc;M Chiorazzi;H Zhao;L Yang;J Powell;WH Wilson;ES Jaffe;R Simon;RD Klausner;LM Staudt Journal of Experimental Medicine 198(6):851-862
Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin lymphoma
A Rosenwald;G Wright;K Leroy;X Yu;P Gaulard;RD Gascoyne;WC Chan;T Zhao;C Haioun;TC Greiner;DD Weisenburger;JC Lynch;JM Vose;JO Armitage;EB Smeland;S Kvaloy;H Holte;J Delabie;E Campo;E Montserrat;A Lopez-Guillermo;G Ott;HK Muller-Hermelink;JM Connors;R Braziel;TM Grogan;RI Fisher;TP Miller;M LeBlanc;M Chiorazzi;H Zhao;L Yang;J Powell;WH Wilson;ES Jaffe;R Simon;RD Klausner;LM Staudt Blood 102(11):#208
Cell cycle alterations in the blastoid variant of mantle cell lymphoma (MCL-BV) as detected by gene expression profiling of mantle cell lymphoma (MCL) and MCL-BV
S de Vos;U Krug;WK Hofmann;GS Pinkus;SH Swerdlow;W Wachsman;TS Grogan;JW Said;HP Koeffler Diagnostic Molecular Pathology 12(1):35-43
2002
Failure of beta-globin gene detection does not predict non-amplification of DNA in JH/Bcl-2 PCR Analysis: insights from a national follicular lymphoma clinical trial
G Fan;RM Braziel;T Grogan Modern Pathology 15(1):240a(#1002)
Gene expression profiling in laser microdissected normal follicular mantles, mantle cell lymphoma (MCL), and blastoid variant of mantle cell lymphoma
S de Vos;U Krug;WK Hofman;GS Pinkus;SH Swerdlow;W Wachsman;T Grogan;C Yue;HP Koeffler;JW Said Modern Pathology 15(1):237a(#991)
The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma
A Rosenwald;G Wright;WC Chan;JM Connors;E Campo;RI Fisher;RD Gascoyne;HK Muller-Hermelink;EB Smeland;LM Staudt;TM Grogan;TP Miller;M LeBlanc New England Journal of Medicine 346(25):1937-1947
Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the international lymphoma study group based on 61 cases
SA Pileri;TM Grogan;NL Harris;P Banks;E Campo;JKC Chan;RD Favera;G Delsol;C De Wolf-Peeters;B Falini;RD Gascoyne;P Gaulard;KC Gatter;PG Isaacson;ES Jaffe;P Kluin;DM Knowles;DY Mason;S Mori;HK Muller-Hermelink;MA Piris;E Ralfkiaer;H Stein;IJ Su;RA Warnke;LM Weiss Histopathology 41:1-29
Major histocompatibility complex (MHC) class II antigen HLA-DR gene expression levels in diffuse large B-Cell lymphoma correlate with survival.
TP Miller;M LeBlanc;TM Grogan;RM Braziel;LM Staudt;RI Fisher Blood 100(11):346a(#1341)
2001
Cellular proteins determined by immunohistochemistry predict outcome in patients with aggressive non-Hodgkin's lymphoma: a first generation model of risk.
TP Miller;TM Grogan;J Unger;R Braziel;M Jaramillo;RI Fisher Blood 98(11):125a(#526)
Biological response to thalidomide in remitting patients with myelodysplastic syndrome (MDS): evidence for induction of neoplastic vascular endothelial growth factor (VEGF) resistance
AF Baker;WT Bellamy;BJ Glinsmann-Gibson;R Heaton;A Buresh;TM Grogan;AF List Blood 98(11):353a(#1490)
Alteration of SMRT tumor suppressor function in transformed non-Hodgkin lymphomas
LJ Coignet;L Song;A Zlobin;C Brigaudeau;S Weijsen;Q Jiang;E Nacheva;E Davis;D Catovsky;T Grogan;L Staudt;RI Fisher;L Miele Blood 98(11):760a(#3164)
1999
Interleukin-6 regulation of matrix metalloproteinase (MMP-2 and MMP-9) and tissue inhibitor of metalloproteinase (TIMP-1) expression in malignant non-Hodgkin's lymphomas
AE Kossakowska;DR Edwards;C Prasinkiewicz;MC Zhang;D Guo;SJ Urbanski;T Grogan;LA Marquez;A Janowska-Wieczorek Blood 94(6):2080-2089
Expression of vascular endothelial growth factor and its receptors in hematopoietic malignancies
WT Bellamy;L Richter;Y Frutiger;TM Grogan Cancer Research 59(3):728-733
1994
Prognostic significance of the Ki-67 associated proliferative antigen in aggressive non-Hodgkin's lymphoma: A prospective Southwest Oncology Group (SWOG) trial.
TP Miller;TM Grogan;S Dahlberg;CM Spier;RM Braziel;PM Banks;K Foucar;CR Kjeldsberg;N Levy;BN Nathwani;B Schnitzer;RR Tubbs;ER Gaynor;RI Fisher Blood 83(6):1460-1466
The presence of bcl-1 and bcl-2 gene rearrangements in diffuse small cleaved-cell lymphoma: A disease with diverse molecular and immunophenotypic findings
CP Leith;CL Willman;CM Spier;TP Miller;TM Grogran Diagnostic Molecular Pathology 3(3):178-183
1993
NCAM (CD56)-positive malignant lymphoma.
WF Kern;CM Spier;TP Miller;TM Grogan Leukemia & Lymphoma 12:1-10
Cytolytic (TIA-1 +) tumor infiltrating lymphocytes in B cell non-Hodgkin's lymphomas.
J Diaz;R Tubbs;M Stoler;T Grogan Leukemia & Lymphoma 9:91-94
Immunobiologic correlates of prognosis in lymphoma.
TM Grogan;TP Miller Seminars in Oncology 20:58-74
1992
Neural cell adhesion molecule-positive peripheral T-cell lymphoma: A rare variant with a propensity for unusual sites of involvement.
WF Kern;CM Spier;EH Hanneman;TP Miller;M Matzner;TM Grogan Blood 79(9):2432-2437
Detection of Epstein-Barr virus genome in Ki-1 (CD30)- positive, large cell anaplastic lymphomas using the polymerase chain reaction.
CW Ross;JA Schlegelmilch;TM Grogan;LM Weiss;B Schnitzer;CA Hanson American Journal of Pathology 141:457-465
Determination of T-cell monoclonality in non-Hodgkin's lymphoma by frozen section immunohistology.
J Diaz;G Segal;R Tubbs;M Stoler;T Grogan Leukemia-Lymphoma 8:477-481
Diffuse small cleave cell lymphoma: A heterogeneous disease with distinct immunobiologic subsets.
CP Leith;CM Spier;TM Grogan;G Gonzales;CS Rangel;JA Rybski;M Matzner;TP Miller JCO 10:1259-1265
Diffuse small cleaved cell lymphoma (DSCL): Correlation of BCL-1 and BCL-2 gene rearrangements with survival.
C Leith;C Willman;C Spier;T Miller;T Grogan Modern Pathology 5(1):81A(#478)
Lineage restricted MDR1 expression in normal blood cells.
WT Klimecki;BW Futscher;LL Blake;TM Grogan;WS Dalton AACR 33:467(#2791)
Molecular analysis of CD3(+) and CD3(-) peripheral T-cell lymphomas (RTCL).
E Hammer;P Suwanjlndar;R Braziel Modern Pathology 5:78A(#458)
1991
Diffuse small cleaved cell lymphoma: A heterogeneous disease with distinct biologic subsets.
C Leith;C Spier;T Grogan;G Gonzales;C Rangel;J Rybski;M Matzner;A Cantu;T Miller U.S. Canadian Academy of Pathology Lab Invest 64:77A(#450)
New biologic markers in non-Hodgkin's lymphomas.
TM Grogan;TP Miller Hematology/Oncology Clinics of North America 5(5):925-933
Patients with localized non-Hodgkin's lymphomas provide opportunities for future research.
TP Miller;TM Grogan Oncology 5(8):127-132
Prediction of outcome in diffuse large cell lymphoma by the major histocompatibility complex class II (HLA-DR, DP, DQ) and class I (HLA-A, B, C) phenotype.
JA Rybski;CM Spier;TP Miller;SM Lippman;DL McGee;TM Grogan Leukemia-Lymphoma 6:31-38
